v3.25.2
Financial Instruments (Tables)
 12 Months Ended
Apr. 30, 2025
Disclosure of detailed information about financial instruments [abstract]  
Schedule of Details of Amounts Receivable and Allowances for Credit Losses Details of amounts receivable and allowance for credit losses as of April 30, 2025, 2024 and 2023 are as follows:

 

(in thousands)

 

2025
$

 

 

2024
$

 

 

2023
$

 

Amounts receivable

 

 

4,165

 

 

 

3,819

 

 

 

3,280

 

Allowance for credit losses

 

 

(50

)

 

 

(29

)

 

 

(33

)

Amounts receivable, net

 

 

4,115

 

 

 

3,790

 

 

 

3,247

 
Summary of Classification and Measurement of Financial Assets and Liabilities

At April 30, 2025, the Company is exposed to currency risk through the following assets and liabilities denominated in US dollars and Euros:

 

 

 

Euros

 

 

US Dollars

 

(in thousands)

 

(€)

 

 

(U.S.$)

 

Cash

 

 

1,237

 

 

 

5,207

 

Amounts receivable

 

 

1,993

 

 

 

732

 

 

 

 

3,230

 

 

 

5,939

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

 

(1,819

)

 

 

(1,872

)

Deferred acquisition payments

 

 

(193

)

 

 

—

 

Leases

 

 

(6,315

)

 

 

—

 

 

 

(8,327

)

 

 

(1,872

)

 

 

 

 

 

 

 

Net

 

 

(5,097

)

 

 

4,067

 
Schedule of Contractual Cash Flow Requirements

Contractual cash flow requirements as of April 30, 2025 were as follows:

 

 

 

< 1
year

 

 

1 - 2
years

 

 

2 - 5
years

 

 

>5
years

 

 

Total

 

(in thousands)

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Accounts payable and accrued liabilities

 

 

5,283

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

5,283

 

Leases

 

 

2,695

 

 

 

2,692

 

 

 

6,733

 

 

 

4,514

 

 

 

16,634

 

Total

 

 

7,978

 

 

 

2,692

 

 

 

6,733

 

 

 

4,514

 

 

 

21,917